Search Jobs

Valuable connections start here.

Search and Apply

To have a more in-depth discussion of a position, contact the recruiter listed on the job posting. Put our 40+ years of experience to work for you!

Senior Actuarial Analyst - Health

Remote, NA 00000

Posted: 05/21/2024 Category: Actuarial Science Job Number: 330736-0_1 Salary: 105,000-$125,000 + Bonus

Job Description

Title: Senior Actuarial Analyst - Health
Location: Remote
Salary: 105,000-$125,000 + Bonus

We are seeking a Senior Actuarial Analyst - VBC Actuary for a crucial role within our growing healthcare provider team. The ideal candidate will have an ASA designation and at least 3 years of experience in Medicare, Provider Contracting, and Risk Scoring. Responsibilities include supporting the development and management of VBC Contracts, Risk Adjustment and accrual models. The role involves assisting in accurate and timely reporting to aid strategic decision-making. Experience working with a Health Plan or Provider is preferred.

Smith Hanley Associates takes pride in being the premier recruiting agency serving the actuarial industry. For over 30 years, we have served both clients and candidates with specialization in analytics and actuarial science. For more information, please visit our website at www.Smithhanley.com

2020RH

Meet Your Recruiter

Rory Hauser
Principal

After finishing his MBA at the John Welch College of Business, Rory joined Smith Hanley in 2015 to recruit in the actuarial and analytics space. He specializes in the placement of actuaries and statistical analytics candidates nationwide. 

Rory has over 15 years business experience in both recruiting and operations providing him the tools necessary to assist both clients and candidates. In his spare time Rory enjoys skiing, mountain biking, and fishing. 

Apply Online
Apply with LinkedIn Apply with Facebook Apply with X

Send an email reminder to:

Share This Job:

Related Jobs:

Login to save this search and get notified of similar positions.

Search Jobs

Contact winsearch at [email protected]

News

Big pharma patent cliffs
Pharmaceutical

Big Pharma’s Patent Cliffs

EY estimates that the top twenty biopharma companies have $180 billion in sales at risk from patent expirations between now and 2028. Why isn t their

Read More